Novartis India Ltd. - Research Center
500672 NOVARTIND Group (B) BSE data
Add to watchlist
| Results |
Half yearly
|
| Statement | |
| More |
Half yearly results in brief
(Rs crore)
| Sep ' 23 | Sep ' 22 | Mar ' 22 | Sep ' 21 | Sep ' 20 | |
|---|---|---|---|---|---|
| Sales | 169.36 | 222.44 | 197.28 | 202.59 | 188.29 |
| Operating profit | 34.28 | 48.12 | 12.18 | 14.93 | 14.40 |
| Interest | 1.17 | 0.99 | 1.79 | 3.04 | 3.34 |
| Gross profit | 62.41 | 80.51 | 30.74 | 24.73 | 23.62 |
| EPS (Rs) | 17.80 | 28.66 | -6.90 | 5.39 | 4.83 |
Half yearly
results in details
| Sep ' 23 | Sep ' 22 | Mar ' 22 | Sep ' 21 | Sep ' 20 | |
|---|---|---|---|---|---|
| Other income | 29.30 | 33.38 | 20.35 | 12.84 | 12.56 |
| Stock adjustment | 13.07 | 13.18 | -11.66 | 2.53 | -5.64 |
| Raw material | - | - | - | - | - |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 11.55 | 20.67 | 46.60 | 55.29 | 55.14 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 110.46 | 140.47 | 150.16 | 129.84 | 124.39 |
| Provisions made | - | - | - | - | - |
| Depreciation | 2.21 | 2.68 | 4.06 | 5.59 | 6.16 |
| Taxation | 16.26 | 7.10 | -5.94 | 5.84 | 5.55 |
| Net profit / loss | 43.94 | 70.73 | -17.02 | 13.30 | 11.91 |
| Extra ordinary item | - | - | -49.64 | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 12.34 | 12.34 | 12.34 | 12.34 | 12.34 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 20.24 | 21.63 | 6.17 | 7.37 | 7.65 |
| GPM (%) | 31.42 | 31.47 | 14.12 | 11.48 | 11.76 |
| NPM (%) | 22.12 | 27.65 | -7.82 | 6.17 | 5.93 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis